Back to News Research News from 2002

Research News From 2002

  1. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. (29 December 2002)
  2. Cognitive Ability and Brain Structure in Type 1 Diabetes: Relation to Microangiopathy and Preceding Severe Hypoglycemia. (29 December 2002)
  3. Discordance Between HbA1c and Fructosamine: Evidence for a glycosylation gap and its relation to diabetic nephropathy. (29 December 2002)
  4. Optimal Dose of Candesartan for Renoprotection in Type 2 Diabetic Patients With Nephropathy: A double-blind randomized cross-over study. (29 December 2002)
  5. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. (29 December 2002)
  6. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. (29 December 2002)
  7. Purified Allogeneic Hematopoietic Stem Cell Transplantation Blocks Diabetes Pathogenesis in NOD Mice. (29 December 2002)
  8. Effects of Injectable or Implantable Progestin-Only Contraceptives on Insulin-Glucose Metabolism and Diabetes Risk. (29 December 2002)
  9. The Rise of Childhood Type 1 Diabetes in the 20th Century (free Medscape membership required). (22 December 2002)
  10. Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). (22 December 2002)
  11. Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. (22 December 2002)
  12. Frequency of coeliac disease in Hungarian children with type 1 diabetes mellitus. (22 December 2002)
  13. Anti-CD38 autoantibodies: Characterisation in new-onset Type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies. (22 December 2002)
  14. IA-2 autoantibodies predict impending Type I diabetes in siblings of patients. (22 December 2002)
  15. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes. (22 December 2002)
  16. Small intestinal glucose absorption and duodenal motility in type 1 diabetes mellitus. (22 December 2002)
  17. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. (22 December 2002)
  18. Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. See also New Screening Recommendations for Celiac Disease (free Medscape membership required). (22 December 2002)
  19. Hypertransaminasemia in pediatric celiac disease patients and its prevalence as a diagnostic clue. (22 December 2002)
  20. No gold at the ends of the glycemic rainbow, an editorial in the Journal of Pediatrics, examines the dangers of DKA. (15 December 2002)
  21. Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema. (15 December 2002)
  22. Lung function abnormalities in children with type I diabetes. (15 December 2002)
  23. End-tidal Carbon Dioxide Predicts the Presence and Severity of Acidosis in Children with Diabetes. (15 December 2002)
  24. Waiting for a Diabetes Cure Part 3: What's on the Horizon? is an interview with Jeffrey Bluestone, Ph.D., from the University of California, San Francisco, California. (15 December 2002)
  25. Prospects for the prevention and reversal of type 1 diabetes mellitus. (15 December 2002)
  26. Challenges for gene therapy of type 1 diabetes. (15 December 2002)
  27. Fatal attraction: chemokines and type 1 diabetes. See also PDF version. (15 December 2002)
  28. ACE inhibitors and protection against kidney disease progression in patients with type 2 diabetes: what's the evidence. (15 December 2002)
  29. Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients. (15 December 2002)
  30. The Baylor College of Medicine has several presentations related to type 2 diabetes online. (15 December 2002)
  31. Type 2 Diabetes Mellitus Among Florida Children and Adolescents, 1994 through 1998. (15 December 2002)
  32. SEARCH for Diabetes in Youth is a multi-year, multi-center study that will estimate the number of young people who have diabetes in the United States and identify the type of diabetes by age and ethnicity. See also the Cincinnati Children's Hospital discussion of the research program. (8 December 2002)
  33. The TRIGR study will examine whether delayed exposure to intact food proteins will reduce the risk of developing type 1 diabetes. Women who are pregnant and who have type 1 diabetes, have a spouse with type 1 diabetes, or another child with type 1 diabetes, are encouraged to participate in the study. (8 December 2002)
  34. The CDC has updated estimates on the prevalence of diabetes. (8 December 2002)
  35. Pertussis infection in childhood and subsequent Type 1 diabetes mellitus. (8 December 2002)
  36. Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members. See also Combinations Of Antibodies Predict Diabetes Risk. (8 December 2002)
  37. Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. See also Chromosome Anomalies Common in Transient Neonatal Diabetes. (Free Medscape membership required) (8 December 2002)
  38. Noninvasive Blood Glucose Monitoring With Optical Coherence Tomography. (8 December 2002)
  39. A Novel Noninvasive Blood Glucose Monitor. (8 December 2002)
  40. Association of HLA-DQ Genotype in Autoantibody-Negative and Rapid-Onset Type 1 Diabetes. (8 December 2002)
  41. The Rise of Childhood Type 1 Diabetes in the 20th Century. (8 December 2002)
  42. Increased Risk of Childhood Type 1 Diabetes in Children Born After 1985. (8 December 2002)
  43. Decreased Mortality Associated With the Use of Metformin Compared With Sulfonylurea Monotherapy in Type 2 Diabetes. (8 December 2002)
  44. Intrauterine Hyperglycemia Is Associated With an Earlier Diagnosis of Diabetes in HNF-1alpha Gene Mutation Carriers. (8 December 2002)
  45. Long-term insulin independence following repeated islet transplantation in totally pancreatectomized diabetic pigs. (8 December 2002)
  46. Intrahepatic Islet Transplantation in Type 1 Diabetic Patients Does Not Restore Hypoglycemic Hormonal Counterregulation or Symptom Recognition After Insulin Independence. (8 December 2002)
  47. Reduction of Blood Glucose Variability in Type 1 Diabetic Patients Treated By Pancreatic Islet Transplantation. (8 December 2002)
  48. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. (8 December 2002)
  49. Ultrasonography of plantar soft tissues thickness in young people with diabetes. (8 December 2002)
  50. Absorption and Metabolic Effect of Inhaled Insulin. (8 December 2002)
  51. End-tidal Carbon Dioxide Predicts the Presence and Severity of Acidosis in Children with Diabetes. (8 December 2002)
  52. Plasma and Dietary Vitamin E in Relation to Incidence of Type 2 Diabetes. (8 December 2002)
  53. A Randomized Controlled Trial of Resistance Exercise Training to Improve Glycemic Control in Older Adults With Type 2 Diabetes. (8 December 2002)
  54. Insulin Resistance and Associated Compensatory Responses in African-American and Hispanic Children. (8 December 2002)
  55. Joslin Researchers Shed Light on Genetic Defects that Cause Diabetes. (1 December 2002)
  56. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. (PDF version) (1 December 2002)
  57. While Tinkering With the Beta-Cell... Metabolic Regulatory Mechanisms and New Therapeutic Strategies. (Free Medscape membership required) (1 December 2002)
  58. Parenting Styles, Regimen Adherence, and Glycemic Control in 4- to 10-Year-Old Children With Diabetes. (1 December 2002)
  59. Brief Report: Posttraumatic Stress Disorder in Parents of Children With Newly Diagnosed Type 1 Diabetes. (1 December 2002)
  60. Peer and Family Support in Children and Adolescents With Type 1 Diabetes. (1 December 2002)
  61. Assessing Friend Support of Adolescents' Diabetes Care: The Diabetes Social Support Questionnaire-Friends Version. (1 December 2002)
  62. "Come on, Say Something, Dad!": Communication and Coping in Fathers of Diabetic Adolescents. (1 December 2002)
  63. The Intersection of Adolescent Development and Intensive Intervention: Age-Related Psychosocial Correlates of Treatment Regimens in the Diabetes Control and Complication Trial. (1 December 2002)
  64. Brief Report: Self-Care Behaviors of Children With Type 1 Diabetes Living in Puerto Rico. (1 December 2002)
  65. Nut and Peanut Butter Consumption and Risk of Type 2 Diabetes in Women. (1 December 2002)
  66. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. (24 November 2002)
  67. New study to compare the safety of HMR1964 and insulin aspart used in continuous subcutaneous infusion in type 1 diabetes. (24 November 2002)
  68. Depression In Juvenile Diabetics Study Seeks Children Ages 8-16 With Type 1 Diabetes . (24 November 2002)
  69. Incidence Data of Childhood-Onset Type I Diabetes in France During 1988-1997: The Case for a Shift Toward Younger Age at Onset. (24 November 2002)
  70. Oral Insulin Product Hexyl-Insulin Monoconjugate 2 (HIM2) in Type 1 Diabetes Mellitus: The Glucose Stabilization Effects of HIM2. (24 November 2002)
  71. Partnership Creates One Of The World's Largest Diabetic Retinopathy Research Centers At Penn State Hershey. (24 November 2002)
  72. UK Announces Results of Diabetic Eye Study. (24 November 2002)
  73. Retinopathy in older patients with diabetes mellitus. See also Elderly Diabetics Have Increased Likelihood Of Developing Diabetic Retinopathy. (24 November 2002)
  74. Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy. (24 November 2002)
  75. Clinical Usefulness of Cystatin C for the Estimation of Glomerular Filtration Rate in Type 1 Diabetes: Reproducibility and accuracy compared with standard measures and iohexol clearance. (24 November 2002)
  76. beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. (24 November 2002)
  77. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. (24 November 2002)
  78. Preferential transmission of type 1 diabetes from parents to offspring: fact or artifact? (17 November 2002)
  79. Coffee consumption and risk of type 2 diabetes mellitus. (17 November 2002)
  80. Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes at Medscape offers the full text of this recent article. (17 November 2002)
  81. Transfer of metformin into human milk. (17 November 2002)
  82. Can diabetes mellitus be induced by medication? (17 November 2002)
  83. Optic disc swelling in an adolescent with insulin dependent diabetes mellitus. (17 November 2002)
  84. The diabetes social support questionnaire-family version: evaluating adolescents' diabetes-specific support from family members. (17 November 2002)
  85. Vascularized islet cell transplantation in miniature Swine: islet-kidney allografts correct the diabetic hyperglycemia induced by total pancreatectomy. (17 November 2002)
  86. Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats. (17 November 2002)
  87. Variation in consumption of cow milk proteins and lower incidence of Type 1 diabetes in Iceland vs the other 4 Nordic countries. (10 November 2002)
  88. Gender differences in the psychological adjustment to type 1 diabetes mellitus: an explorative study. (10 November 2002)
  89. Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis. (10 November 2002)
  90. Prevalence of retinopathy differs with age at onset of diabetes in a population of patients with Type 1 diabetes. (10 November 2002)
  91. Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy. (10 November 2002)
  92. Cardiovascular autonomic reactivity is decreased in adolescents with Type 1 diabetes. (10 November 2002)
  93. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients. (10 November 2002)
  94. Predictors of coping strategy selection in paediatric patients. (10 November 2002)
  95. Diabetic ketoacidosis associated with Metabolife: a report of two cases. (10 November 2002)
  96. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus. (10 November 2002)
  97. Maternal diabetes mellitus and infant malformations. (10 November 2002)
  98. Novo Nordisk submits Marketing Authorisation Application for NN304 (insulin detemir), a new long-acting insulin analogue. See also Novo Nordisk: long-acting insulin to take on Aventis. (10 November 2002)
  99. CWD Foundation Awards Largest Grant to Date to the Diabetes Research Institute. (3 November 2002)
  100. Identification of Insulin-Producing Cells Derived from Embryonic Stem Cells by Zinc-Chelating Dithizone. Free full text available in HTML and PDF. (3 November 2002)
  101. Glucose-responsive insulin-producing cells from stem cells. (3 November 2002)
  102. A type 1 diabetes-related protein from wheat (triticum aestivum): cDNA clone of a wheat storage globulin, Glb1, linked to islet damage. (Free full text as PDF.) (3 November 2002)
  103. Establishment of T cell lines to bovine b-casein and b-casein derived epitopes in patients with type 1 diabetes. (3 November 2002)
  104. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes . (3 November 2002)
  105. The Epidemiology of Type 1 Diabetes in Children in Philadelphia 1990–1994: Evidence of an epidemic. (3 November 2002)
  106. Personal Control and Disordered Eating in Female Adolescents With Type 1 Diabetes. (3 November 2002)
  107. Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes. (3 November 2002)
  108. Prevention of Hypoglycemia Using Risk Assessment With a Continuous Glucose Monitoring System. (3 November 2002)
  109. Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type I. (3 November 2002)
  110. Reduction of the Accumulation of Advanced Glycation End Products by ACE Inhibition in Experimental Diabetic Nephropathy. (3 November 2002)
  111. Ultrasonic evaluation of early atherosclerosis in children and adolescents with type 1 diabetes mellitus. (27 October 2002)
  112. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. (27 October 2002)
  113. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes. (27 October 2002)
  114. Increase in the incidence of type 1 diabetes mellitus in children in three cities in Poland, 1987-1999. (27 October 2002)
  115. Current knowledge of Japanese type 1 diabetic syndrome. (27 October 2002)
  116. Clinical characteristics and predictors of severe ketoacidosis at onset of type 1 diabetes mellitus in children in a North Rhine-Westphalian region, Germany. (27 October 2002)
  117. Oral Insulin Product Hexyl-Insulin Monoconjugate 2 (HIM2) in Type 1 Diabetes Mellitus: The Glucose Stabilization Effects of HIM2. (27 October 2002)
  118. Portal venous pressure changes after sequential clinical islet transplantation. (27 October 2002)
  119. In Pursuit of Type 1 Diabetes Prevention. (20 October 2002)
  120. Immunological Markers in the Diagnosis and Prediction of Autoimmune Type 1a Diabetes. (20 October 2002)
  121. On the Forefront of a New Paradigm in the Treatment of Diabetes? Quite Possibly. (Free Medscape registration required) (20 October 2002)
  122. Naturally Occurring Protein Protects Human Islet Cells from Death. (20 October 2002)
  123. Depression in Type 1 diabetes in children. Natural history and correlates. (20 October 2002)
  124. Many more readers have written responses to the recently published Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. (20 October 2002)
  125. Treatment of Chronic Painful Diabetic Neuropathy With Isosorbide Dinitrate Spray. (20 October 2002)
  126. The use of lamellar body counts to predict fetal lung maturity in pregnancies complicated by diabetes mellitus. (20 October 2002)
  127. Correction for insulin-dependent diabetes in maternal serum alpha-fetoprotein testing has outlived its usefulness. (20 October 2002)
  128. Testing the NKT cell hypothesis of human IDDM pathogenesis. (13 October 2002)
  129. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes. (13 October 2002)
  130. Growth and Body Composition in Type 1 Diabetes mellitus. (13 October 2002)
  131. Markers of insulin resistance in day and shift workers aged 30-59 years. (13 October 2002)
  132. The role of viruses in human diabetes. (13 October 2002)
  133. Peptide therapy for Type I diabetes: the immunological homunculus and the rationale for vaccination. (13 October 2002)
  134. Immunologic and genetic factors in type 1 diabetes. (Full text) (6 October 2002)
  135. Natural History of beta-Cell Autoimmunity in Young Children with Increased Genetic Susceptibility to Type 1 Diabetes Recruited from the General Population. (6 October 2002)
  136. Family history and risk of type 1 diabetes mellitus. (6 October 2002)
  137. Subclinical pain and thermal sensory dysfunction in children and adolescents with Type 1 diabetes mellitus. (6 October 2002)
  138. Leptin levels in patients with type 1 diabetes receiving intensive insulin therapy compared with those in patients receiving conventional insulin therapy. (6 October 2002)
  139. Dissimilarity in adolescent and maternal representations of Type 1 diabetes: exploration of relations to adolescent well-being. (6 October 2002)
  140. Diabetes trends in Europe. (6 October 2002)
  141. Diabetes trends in Latin America. (6 October 2002)
  142. Diabetes trends in Africa. (6 October 2002)
  143. Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus. (6 October 2002)
  144. Absence of otoacoustic emissions in insulin-dependent diabetic patients. Is there evidence for diabetic cochleopathy? (6 October 2002)
  145. Transplantation of islets of Langerhans: new developments. (29 September 2002)
  146. Xenotransplantation of pig islets in diabetic dogs with use of a microcapsule composed of agarose and polystyrene sulfonic Acid mixed gel. (29 September 2002)
  147. NIDDK announces Type 1 Diabetes TrialNet. (22 September 2002)
  148. Antibodies to bovine Beta-casein in diabetes and other autoimmune diseases. (22 September 2002)
  149. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. (22 September 2002)
  150. Professor warns of "brain drain" of diabetes researchers from Europe. (22 September 2002)
  151. Rorschach variables related to blood glucose control in insulin-dependent diabetes patients. (22 September 2002)
  152. Data mining a diabetic data warehouse. (22 September 2002)
  153. Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes. (15 September 2002)
  154. High and low hemoglobin glycation phenotypes in type 1 diabetes. A challenge for interpretation of glycemic control. (8 September 2002)
  155. Insulin resistance and atherosclerosis in diabetes mellitus. (8 September 2002)
  156. Eiffel Technologies Announces Breakthrough Insulin Study. (8 September 2002)
  157. The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention. (8 September 2002)
  158. Hybrid insulin cocrystals for controlled release delivery. See also New Insulin Formulation Could Steady Glucose Control. (8 September 2002)
  159. Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study. (8 September 2002)
  160. Type-2 diabetes family history delays the onset of type-1 diabetes. (8 September 2002)
  161. Anticardiolipin antibodies in children with insulin-dependent diabetes mellitus. (8 September 2002)
  162. Diabetic kidneys can safely expand the donor pool. (8 September 2002)
  163. The Transplantation Society recently held its International Congress. The following press releases are from the Congress: (1 September 2002)
    1. Islet Cell Transplantation For Diabetes Turns Corner With More Widespread Success, Researchers Say At International Congress Of The Transplantation Society.
    2. Cloning Pigs And Drug Discovery Among "Hot" Topics Discussed At International Congress Of The Transplantation Society.
    Also see the following news reports:
    1. Success of Cell Transplants for Diabetes Improving.
    2. Pig Cells Used to Treat Type 1 Diabetes.
    3. Pig-cell transplant treats diabetes.
  164. Acidic Drinking Water and Risk of Childhood-Onset Type 1 Diabetes. (1 September 2002)
  165. Pupil Signs of Sympathetic Autonomic Neuropathy in Patients With Type 1 Diabetes. (1 September 2002)
  166. Intravenous Glargine and Regular Insulin Have Similar Effects on Endogenous Glucose Output and Peripheral Activation/Deactivation Kinetic Profiles. (1 September 2002)
  167. Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort. See also our page about diabetes and immunizations. (25 August 2002)
  168. New trends in the treatment of diabetic nephropathy in children.. (25 August 2002)
  169. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. (25 August 2002)
  170. Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. (25 August 2002)
  171. Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. (25 August 2002)
  172. The FDA issued a Xenotransplantation Advisory. (18 August 2002)
  173. TRIGR (Trial to Reduce Insulin-Dependent Diabetes in the Genetically at Risk) will determine if a delay of dietary exposure to intact foreign food proteins can reduce the risk of developing Type 1 diabetes in children genetically predisposed to the disease. See also TRIGR Study: A New Trial Investigates Environmental Triggers in Type 1 Diabetes by the JDRF. (11 August 2002)
  174. Abnormalities of the electrocardiogram during hypoglycaemia: the cause of the dead in bed syndrome? (11 August 2002)
  175. Diabetes and Suicidal Ideation Among Youth in the Community. (11 August 2002)
  176. ISPAD (International Society for Pediatric and Adolescent Diabetes) has an excellent collection of articles in PDF format from the Second International Novo Nordisk Symposium on Childhood Diabetes, held June 1-2, 2001 in Copenhagen. (4 August 2002)
  177. Amylin Replacement With Pramlintide in Type 1 and Type 2 Diabetes: A Physiological Approach to Overcome Barriers With Insulin Therapy. (4 August 2002)
  178. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. (4 August 2002)
  179. Lack of physiological suppression of circulating IGFBP-1 in puberty in patients with insulin-dependent diabetes mellitus. (4 August 2002)
  180. Space-time clustering of childhood Type 1 diabetes in Devon and Cornwall, England. (4 August 2002)
  181. Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes. (4 August 2002)
  182. Hypoglycaemia unawareness and the brain. (4 August 2002)
  183. Evidence from twins for acquired cellular immune hyperactivity in type 1 diabetes. (4 August 2002)
  184. Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria. (4 August 2002)
  185. New trends in the treatment of diabetic nephropathy in children. (4 August 2002)
  186. Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. (4 August 2002)
  187. Clustering of Cases of Insulin Dependent Diabetes (IDDM) Occurring Three Years After Hemophilus Influenza B (HiB) Immunization Support Causal Relationship Between Immunization and IDDM. (4 August 2002)
  188. First human trial of pancreatic islet allo-transplantation in Korea--focus on re-transplantation. (28 July 2002)
  189. Preservation of Human Islet Cell Functional Mass by Anti-Oxidative Action of a Novel SOD Mimic Compound. See also Improving the Odds in Treating Type I Diabetes: Synthetic antioxidants protect insulin-producing cells during transplants . (28 July 2002)
  190. Distribution of HbA1c Levels For Children and Young Adults in the U.S. (28 July 2002)
  191. Maternal First-Trimester Enterovirus Infection and Future Risk of Type 1 Diabetes in the Exposed Fetus. (28 July 2002)
  192. Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. (28 July 2002)
  193. Thyroid Autoimmunity in Children and Adolescents With Type 1 Diabetes. (28 July 2002)
  194. Evidence of autoantibodies to glutamic acid decarboxylase in oral fluid of type 1 diabetic patients. (28 July 2002)
  195. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. See also Niacin Found Effective in Diabetes. (28 July 2002)
  196. Digital Retinal Images and Teleophthalmology for Detecting and Grading Diabetic Retinopathy. (28 July 2002)
  197. The British Medical Journal recently published an editorial about Diabetic nephropathy. (28 July 2002)
  198. Silent Coronary Atheromatosis in Type 1 Diabetic Patients and Its Relation to Long-Term Glycemic Control. (28 July 2002)
  199. Blood Pressure, Lipids, and Obesity Are Associated With Retinopathy. (28 July 2002)
  200. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. (28 July 2002)
  201. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. (28 July 2002)
  202. Association of British Clinical Diabetologists (ABCD): survey of specialist diabetes care services in the UK, 2000. (28 July 2002)
  203. Diabetes care in childhood and adolescence calls for the "provision of a uniform, equitable and first class paediatric service throughout the UK." (28 July 2002)
  204. Childhood and adolescent diabetes mellitus in Arabs residing in the United Arab Emirates. See also full text PDF. (28 July 2002)
  205. Screening and follow-up of diabetic retinopathy using a new mosaic 9-field fundus photography system. See also full text PDF. (28 July 2002)
  206. Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy. (28 July 2002)
  207. The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery. (28 July 2002)
  208. Glycemic index: overview of implications in health and disease. (28 July 2002)
  209. Pig cells used to treat diabetic children. (14 July 2002)
  210. JDRF offers Inhaled Insulin: A Progress Report. (14 July 2002)
  211. Psychopathology and child and adolescent type 1 diabetes mellitus outcome. (14 July 2002)
  212. Diabetes mellitus in the first year of life. (14 July 2002)
  213. Insulin resistance in type 1 diabetes. (14 July 2002)
  214. Progress in the treatment of childhood diabetes mellitus and obesity. (14 July 2002)
  215. The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983 to 1998. (14 July 2002)
  216. Further evidence for the rising incidence of childhood Type 1 diabetes in Kuwait. (14 July 2002)
  217. National incidence of type 1 diabetes in childhood and adolescence in Ireland. (14 July 2002)
  218. Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among native canadians. (14 July 2002)
  219. Gene and cell therapies for diabetes mellitus: strategies and clinical potential. (14 July 2002)
  220. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. (14 July 2002)
  221. Atrial natriuretic peptide-induced microalbuminuria is associated with endothelial dysfunction in noncomplicated type 1 diabetes patients. (14 July 2002)
  222. Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. (14 July 2002)
  223. Diabetes mellitus-related autoantibodies in childhood autoimmune hepatitis. (14 July 2002)
  224. Effect of darkness on inner retinal hypoxia in diabetes. PDF version. (Free registration required) (30 June 2002)
  225. Successful Islet Transplantation: Continued Insulin Reserve Provides Long-Term Glycemic Control. (30 June 2002)
  226. Elimination of Dietary Gluten Does Not Reduce Titers of Type 1 Diabetes-Associated Autoantibodies in High-Risk Subjects. (30 June 2002)
  227. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. (30 June 2002)
  228. Endothelial Dysfunction Relates to Folate Status in Children and Adolescents With Type 1 Diabetes. (30 June 2002)
  229. Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria? (30 June 2002)
  230. Monkey Stem Cells Produce Insulin in Experiment. See also Induction of Insulin Production from Non-Human Primate Embryonic Stem Cells. (23 June 2002)
  231. Permanent diabetes mellitus in the first year of life. (23 June 2002)
  232. No evidence for accumulation of insulin glargine (LANTUS(R)): a multiple injection study in patients with Type 1 diabetes. (23 June 2002)
  233. Evaluation of the Reproductive Toxicity and Embryotoxicity of Insulin Glargine (LANTUS) in Rats and Rabbits. (23 June 2002)
  234. Evaluation of the Carcinogenic Potential of Insulin Glargine (LANTUS) in Rats and Mice. (23 June 2002)
  235. Nighttime Lows in Diabetic Children. (23 June 2002)
  236. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. (23 June 2002)
  237. Angiopathy in children with diabetes. (23 June 2002)
  238. Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes. (23 June 2002)
  239. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes. (16 June 2002)
  240. Advanced glycation end products in children with chronic renal failure and type 1 diabetes. (16 June 2002)
  241. Number of people with type 2 diabetes in Britain will increase by 40% by 2023, says report. (16 June 2002)
  242. Autonomy development in adolescents with insulin dependent diabetes mellitus. (9 June 2002)
  243. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. See also Pancreatic Cells Formed From Liver Stem Cells. (9 June 2002)
  244. Pancreas Transplantation: Improved Results in the Current Immunosuppressive Era. (Free Medscape registration required) (9 June 2002)
  245. New Treatment Arrests Progression of Type 1 Diabetes in Newly Diagnosed Patients. (2 June 2002)
  246. Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus reports on the failure of injected insulin to delay or prevent the development of type 1 diabetes in high-risk individuals, which was being investigated in the Diabetes Prevention Trial - Type 1 (DPT-1). (2 June 2002)
  247. Beta cell expression of IGF-I leads to recovery from type 1 diabetes. See also Full Text and PDF Reprint. (2 June 2002)
  248. Rick Mendosa writes about IGNAP Peptide. (2 June 2002)
  249. Eight Successful Islet Transplant Recipients Attend JDRF's 32nd Annual Conference. (2 June 2002)
  250. Oral Sulodexide Reduces Albuminuria in Microalbuminuric and Macroalbuminuric Type 1 and Type 2 Diabetic Patients: The Di.N.A.S. Randomized Trial. (2 June 2002)
  251. Clinical outcomes of pregnancy in women with type 1 diabetes. (2 June 2002)
  252. Characterization of the T-cell response to coxsackievirus b4: evidence that effector memory cells predominate in patients with type 1 diabetes. (2 June 2002)
  253. Structural changes in renal arterioles in Type I diabetic patients. (2 June 2002)
  254. Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients. (2 June 2002)
  255. Genetic Studies of Late Diabetic Complications: The Overlooked Importance of Diabetes Duration Before Complication Onset. (2 June 2002)
  256. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. (2 June 2002)
  257. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. (2 June 2002)
  258. Use of In Vitro-Generated, Stem Cell-Derived Islets to Cure Type 1 Diabetes. (Full Text) (26 May 2002)
  259. A View on Beta Cell Transplantation in Diabetes. (Full Text) (26 May 2002)
  260. Latent Autoimmune Diabetes in Adults. (Full Text) (26 May 2002)
  261. Insulin Intervention to Preserve Beta Cells in Slowly Progressive Insulin-Dependent (Type 1) Diabetes Mellitus. (Full Text) (26 May 2002)
  262. Coeliac disease in children and adolescents with type 1 diabetes: a study of growth, glycaemic control, and experiences of families. (26 May 2002)
  263. Autoantibodies in children with type 2 diabetes mellitus. (26 May 2002)
  264. Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. (26 May 2002)
  265. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes". (26 May 2002)
  266. Treatment of type 2 diabetes mellitus in children and adolescents. (26 May 2002)
  267. Management of hyperglycemia in minority children with type 2 diabetes mellitus. (26 May 2002)
  268. The role of the family in managing therapy in minority children with type 2 diabetes mellitus. (26 May 2002)
  269. In the current issue of Diabetes Care, Is Postprandial Glucose Control Important? explores the question of post-meal control for people with type 2 diabetes. See also Importance of Postprandial Glucose Control from September 2001. (26 May 2002)
  270. Relation between Course of Disease in Type 1 Diabetes and Islet Cell Antibodies. (Full Text) (26 May 2002)
  271. Characterization of the T-Cell Response to Coxsackievirus B4. (26 May 2002)
  272. Enterovirus RNA Is Found in Peripheral Blood Mononuclear Cells in a Majority of Type 1 Diabetic Children at Onset. (26 May 2002)
  273. Viruses and Diabetes. (Full Text) (26 May 2002)
  274. Molecular Mimicry in Type 1 Diabetes: Immune Cross-Reactivity between Islet Autoantigen and Human Cytomegalovirus but Not Coxsackie Virus. (Full Text) (26 May 2002)
  275. The Gut Immune System and Type 1 Diabetes. (Full Text) (26 May 2002)
  276. Could Parenting Stress and Lack of Support/Confidence Function as Mediating Mechanisms between Certain Environmental Factors and the Development of Autoimmunity in Children? (Full Text) (26 May 2002)
  277. Diabetes in the parents of children with Type I diabetes. (26 May 2002)
  278. Researchers Uncover the Remaining Critical Insulin Gene Regulatory Factor. (26 May 2002)
  279. The May 15, 2002 issue of JAMA has many articles about diabetes. Selected articles include: (19 May 2002)
    1. Ethnic Disparities in Diabetic Complications in an Insured Population.
    2. Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes.
    3. Effect of Intensive Therapy on the Microvascular Complications of Type 1 Diabetes Mellitus.
    4. Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management.
    5. Progress and Promise of Diabetes.
    6. Frequency of Inappropriate Metformin Prescriptions.
  280. Bedside scoring procedure for the diagnosis of diabetic peripheral neuropathy in young patients with type 1 diabetes mellitus. (19 May 2002)
  281. Anti-HBs response to standard hepatitis B vaccination in children and adolescents with diabetes mellitus. (19 May 2002)
  282. Effect of coincident enterovirus infection and cows' milk exposure on immunisation to insulin in early infancy. (19 May 2002)
  283. Diabetes in the parents of children with Type I diabetes. (19 May 2002)
  284. Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus. (19 May 2002)
  285. Structural changes in renal arterioles in Type I diabetic patients. (19 May 2002)
  286. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. (19 May 2002)
  287. Gestational diabetes and maternal third-trimester blood count. (19 May 2002)
  288. Perception of risk of developing diabetes in offspring of type 2 diabetic patients. (19 May 2002)
  289. Comparison of blood glucose stability and HBA1C between implantable insulin pumps using U400 HOE 21Ph insulin and external pumps using lispro in type 1 diabetic patients: a pilot study. (12 May 2002)
  290. Enzymatic markers of salivary cell injury in saliva of type 1 diabetic children. (12 May 2002)
  291. Work on developing a prototype wearable 'artificial pancreas' to improve care and lifestyle for diabetic people is showing "very encouraging results" at City University, London. (12 May 2002)
  292. Diamyd Medical is starting the third group of 12 patients of the ongoing vaccine study with its GAD-based vaccine Diamyd. (12 May 2002)
  293. Inhale Reports on Phase III Exubera Inhaled Insulin Data Presented at Endocrinologists' Conference. (5 May 2002)
  294. Special Cell Prevents Diabetes In Mouse Model, Report University Of Pittsburgh Researchers At American Transplant Congress. (5 May 2002)
  295. General Screening for Celiac Disease is Advisable in Children with Type 1 Diabetes. (5 May 2002)
  296. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study finds the prevalence of celiac disease in patients with type 1 diabetes is approximately 20 times higher than in the general population. (5 May 2002)
  297. Immune Responses to Insulin Aspart and Biphasic Insulin Aspart in People With Type 1 and Type 2 Diabetes. (5 May 2002)
  298. Impact of Simultaneous Pancreas and Kidney Transplantation on Progression of Coronary Atherosclerosis in Patients With End-Stage Renal Failure due to Type 1 Diabetes. (5 May 2002)
  299. Domperidone is more effective than cisapride in children with diabetic gastroparesis. (5 May 2002)
  300. Screening for Vascular Complications in Children and Adolescents with Type 1 Diabetes mellitus. (5 May 2002)
  301. Natural course of preclinical type 1 diabetes. (5 May 2002)
  302. Childhood diabetes: a global perspective. (5 May 2002)
  303. Islet cell transplantation and other new technologies for treating type 1 diabetes: a paediatric view. (5 May 2002)
  304. Type 2 diabetes in children: clinical aspects and risk factors. (5 May 2002)
  305. Children with type 2 diabetes: the risks of complications. (5 May 2002)
  306. Delayed Gastric Emptying and Gastric Autoimmunity in Type 1 Diabetes. (28 April 2002)
  307. Predisposition to Atopic Symptoms to Inhaled Antigens May Protect From Childhood Type 1 Diabetes. (28 April 2002)
  308. Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients. (28 April 2002)
  309. Domperidone is more effective than cisapride in children with diabetic gastroparesis. (28 April 2002)
  310. Evaluation of Liver Function in Type 2 Diabetic Patients During Clinical Trials. (28 April 2002)
  311. Chromosomal anomalies among the offspring of women with gestational diabetes. (28 April 2002)
  312. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. (28 April 2002)
  313. A patient with subcutaneous-insulin resistance treated by insulin lispro plus heparin. (28 April 2002)
  314. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. (28 April 2002)
  315. Parental hypertension and 24 h-blood pressure in children prior to diabetic nephropathy. (21 April 2002)
  316. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. (21 April 2002)
  317. Diabetic nephropathy in children and adolescents and its consequences in adults. (21 April 2002)
  318. Autonomic neuropathy in children and adolescents with diabetes mellitus. (21 April 2002)
  319. Diabetic patients can safely undergo vascular surgery, claim US researchers. (21 April 2002)
  320. Relationship between the Effects of Cisapride on Gastric Emptying and Plasma Glucose Concentrations in Diabetic Gastroparesis. (21 April 2002)
  321. Should pediatric patients with hyperlipidemia receive drug therapy? (21 April 2002)
  322. Procter & Gamble Announces Strategic Alliance with GMP Companies for Novel Treatment of Diabetes Mellitus. (21 April 2002)
  323. Chromosomal Anomalies among the Offspring of Women with Gestational Diabetes. (21 April 2002)
  324. Increasing incidence of type 2 diabetes in children and adolescents: treatment considerations. (21 April 2002)
  325. Is coeliac disease more prevalent in young adults with coexisting Type 1 diabetes mellitus and autoimmune thyroid disease compared with those with Type 1 diabetes mellitus alone? (14 April 2002)
  326. Psychomotor development in the children of mothers with type 1 diabetes mellitus or gestational diabetes mellitus. (14 April 2002)
  327. Congenital anomalies in the offspring of women with Type 1, Type 2 and gestational diabetes. (14 April 2002)
  328. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. (14 April 2002)
  329. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.. (14 April 2002)
  330. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. (14 April 2002)
  331. INGAP As A Cure For Diabetes provides a research history of INGAP and islet regeneration and reviews plans for future development. (14 April 2002)
  332. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. (14 April 2002)
  333. Risk of non-Hodgkin lymphoma in celiac disease. (14 April 2002)
  334. Cellular Basis of Diabetic Nephropathy. (Free Medscape membership required) (14 April 2002)
  335. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. (14 April 2002)
  336. Seasonality of birth in patients with type 1 diabetes. (7 April 2002)
  337. Researchers Suggest Cause for Neural Tube Defects in Babies of Mothers with Diabetes. (7 April 2002)
  338. St Vincent's Declaration 10 years on: outcomes of diabetic pregnancies. (7 April 2002)
  339. Psychomotor development in the children of mothers with type 1 diabetes mellitus or gestational diabetes mellitus. (7 April 2002)
  340. Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus. (7 April 2002)
  341. Paraoxonase gene cluster is a genetic marker for early microvascular complications in Type 1 diabetes. (7 April 2002)
  342. Effect of captopril on left ventricular diastolic dysfunction in young insulin dependent diabetic patients with microalbuminuria. (7 April 2002)
  343. Clinical characteristics of non-immune-mediated, idiopathic type 1 (type 1B) diabetes mellitus in Japanese children and adolescents. (7 April 2002)
  344. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. (7 April 2002)
  345. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. (7 April 2002)
  346. Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings. (7 April 2002)
  347. Risk assessment for developing type 1 diabetes: intentions of behavioural changes prior to risk notification. (7 April 2002)
  348. A lower prevalence of atopy symptoms in children with type 1 diabetes mellitus. (7 April 2002)
  349. Fetal pig beta cells are resistant to the toxic effects of human cytokines1. (31 March 2002)
  350. Fructose Amplifies Counterregulatory Responses to Hypoglycemia in Humans. (31 March 2002)
  351. Impaired beta-Cell Function, Incretin Effect, and Glucagon Suppression in Patients With Type 1 Diabetes Who Have Normal Fasting Glucose. (31 March 2002)
  352. The American Diabetes Assocation has published a position statement about The Prevention or Delay of Type 2 Diabetes. (31 March 2002)
  353. alpha-Tocopherol Supplementation Decreases Plasminogen Activator Inhibitor-1 and P-Selectin Levels in Type 2 Diabetic Patients. (31 March 2002)
  354. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. (31 March 2002)
  355. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. (31 March 2002)
  356. A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes. (31 March 2002)
  357. Stature at time of diagnosis of type 1 diabetes mellitus. (31 March 2002)
  358. Cellular Basis of Diabetic Nephropathy. (Free registration required) (31 March 2002)
  359. Measuring Outcomes of Type 2 Diabetes Disease Management Program in an HMO Setting. (Free registration required) (31 March 2002)
  360. Effects of a Community Pharmacist-Based Diabetes Patient-Management Program on Intermediate Clinical Outcome Measures. (Free registration required) (31 March 2002)
  361. Attitudes of Internal Medicine Physicians Toward Type 2 Diabetes. (Free registration required) (31 March 2002)
  362. Type 1 Diabetes Mellitus and Epilepsia Partialis Continua in a 6-Year-Old Boy With Elevated Anti-GAD65 Antibodies. (31 March 2002)
  363. Carpal tunnel syndrome in patients with diabetic polyneuropathy. (See also Tests Miss Carpal Tunnel Syndrome in Diabetics.) (31 March 2002)
  364. Controversy surrounds proposed xenotransplant trial. (24 March 2002)
  365. The Vatican has an excellent introduction to the science and ethics of xenotransplantation. (24 March 2002)
  366. Islet cell transplantation tolerance. (24 March 2002)
  367. JDRF funds stem cell research in Sweden and islet transplantation research at Emory University. (24 March 2002)
  368. One-step immunochromatographic assay for screening of coeliac disease. (PDF version) (24 March 2002)
  369. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes. (24 March 2002)
  370. Protein kinase C and the development of diabetic vascular complications. (24 March 2002)
  371. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1 and VEGF. (24 March 2002)
  372. Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular out-patient education adapted for pregnancy. (24 March 2002)
  373. Cook Islands set to back pig transplants. (17 March 2002)
  374. Researchers Suggest Cause for Neural Tube Defects in Babies of Mothers with Diabetes. (17 March 2002)
  375. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. (Full text from the American Journal of Kidney Diseases) (17 March 2002)
  376. Micro-angiopathic and psychological risk in children and adolescents with type 1 diabetes. (17 March 2002)
  377. Serum leptin concentrations in children with type 1 diabetes mellitus: Relationship to body mass index, insulin dose, and glycemic control. (17 March 2002)
  378. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. (17 March 2002)
  379. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. (17 March 2002)
  380. Trends in the incidence of childhood diabetes in south Asians and other children in Bradford, UK. (17 March 2002)
  381. Identification of Children with Early Onset and High Incidence of Anti-islet Autoantibodies. (17 March 2002)
  382. Yale Study Shows 25 Per Cent of Obese Children Are at High Risk for Developing Diabetes. (17 March 2002)
  383. GAD65 and IA-2 autoantibodies are common in a subset of siblings of Sardinian Type 2 diabetes families. (17 March 2002)
  384. Incidence and seasonal variation of Type 1 diabetes in children in Farwania area, Kuwait (1995-1999). (17 March 2002)
  385. Parents who have kids on an insulin pump are encouraged to participate in a new research study about pump use in kids by completing a simple questionnaire. (10 March 2002)
  386. Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. (10 March 2002)
  387. Disability and its economic impact among adults with diabetes. (10 March 2002)
  388. Researchers Identify Protein in Liver That Clears Insulin From Blood; Find Could Lead to Cure for Type 2 Diabetes. (10 March 2002)
  389. Socioeconomic Status of Women with Diabetes --- United States, 2000. (10 March 2002)
  390. Ixion Awarded NIH Grant for Research Aimed At Treating Insulin-Dependent Diabetes. (10 March 2002)
  391. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. (3 March 2002)
  392. Successful Prospective Prediction of Type 1 Diabetes in Schoolchildren Through Multiple Defined Autoantibodies. (3 March 2002)
  393. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes. (3 March 2002)
  394. Risk Indicators Predictive for Severe Hypoglycemia During the First Trimester of Type 1 Diabetic Pregnancy. (3 March 2002)
  395. Molecular Detection of Circulating beta-Cells After Islet Transplantation. (3 March 2002)
  396. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic Beta cells. (3 March 2002)
  397. Considerations for successful transplantation of encapsulated pancreatic islets. (3 March 2002)
  398. Infant Immunizations Not Shown to Be Harmful to Children's Immune Systems. (3 March 2002)
  399. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. (3 March 2002)
  400. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. (3 March 2002)
  401. Dietary Fat and Meat Intake in Relation to Risk of Type 2 Diabetes in Men. (3 March 2002)
  402. Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. (3 March 2002)
  403. First cases of type 2 diabetes found in white UK teenagers. (3 March 2002)
  404. Oral Diabetes Drug Shows Promise In Preventing Miscarriage In Common Infertility Disorder. (3 March 2002)
  405. A Closed-loop Approach to Regulate Blood Glucose Concentrations in Type 1 Diabetics, presented at the Diabetes Technology Conference held in San Francisco in November 2001, examines the state of the science surrounding the building a closed-loop artificial pancreas. (24 February 2002)
  406. Mortality in Concurrent Type 1 Diabetes and Anorexia Nervosa. (24 February 2002)
  407. Severity at onset of childhood type 1 diabetes in countries with high and low incidence of the condition. (24 February 2002)
  408. Peripheral neuropathy offers an excellent introduction to this complication of diabetes. (24 February 2002)
  409. Obesity and Treatment of Diabetes With Glyburide May Both Be Risk Factors for Acute Pancreatitis. (24 February 2002)
  410. Leptin-Replacement Therapy for Lipodystrophy. (24 February 2002)
  411. The University of Texas Health Science Center at Houston is conducting a Newly Diagnosed Diabetes Mellitus Study to determine whether ingested (oral) human recombinant interferon will preserve residual beta cell function. They are recruiting newly diagnosed kids with type 1 diabetes from all over the US who are willing to travel four times per year to the Texas or Maryland (the NIH Bethesda campus) study centers. (17 February 2002)
  412. Impaired intellectual development in children with Type I diabetes: association with HbA1 c, age at diagnosis and sex. (17 February 2002)
  413. Vitamin A, retinol binding protein and lipids in type 1 diabetes mellitus. (17 February 2002)
  414. Insulin-specific tolerance in diabetes. (17 February 2002)
  415. Relation of diabetic patients' health-related control appraisals and physician-patient interpersonal impacts to patients' metabolic control and satisfaction with treatment. (17 February 2002)
  416. In vitro test of new biomaterials for the development of a bioartificial pancreas. (17 February 2002)
  417. Metabolic impact of puberty on the course of type 1 diabetes. (17 February 2002)
  418. The dynamics of coping and adaptating to the impact when diagnosed with diabetes. (17 February 2002)
  419. Carotid Artery Intima-Media Thickness in Children With Type 1 Diabetes. (17 February 2002)
  420. Technology to Help Diabetics reports on exciting work on glucose sensing underway at the Lawrence Livermore National Laboratory. (10 February 2002)
  421. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (10 February 2002)
  422. The Genetics of Kidneys in Diabetes (GoKinD) study is exploring how genes contribute to the development of diabetic kidney disease. (10 February 2002)
  423. Gene find to aid diabetes research. (10 February 2002)
  424. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany - results from the CODE-2TM study. (10 February 2002)
  425. Stability of U-10 and U-50 dilutions of insulin lispro. (10 February 2002)
  426. TechnosphereTM/Insulin - proof of concept study with a new insulin formulation for pulmonary delivery. (10 February 2002)
  427. Partial elective pancreatectomy is curative in focal form of permanent hyperinsulinemic hypoglycaemia in infancy. (10 February 2002)
  428. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-a suppression. (3 February 2002)
  429. Nutrition Education Improves Metabolic Outcomes among Older Adults with Diabetes Mellitus. (3 February 2002)
  430. Islet yield remains a problem in islet autotransplantation. (3 February 2002)
  431. Continuous Subcutaneous Glucose Monitoring in Diabetic Patients: A multicenter analysis. (3 February 2002)
  432. Intensive insulin treatment in diabetic children. (27 January 2002)
  433. Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. (27 January 2002)
  434. The concept of self-management of type 1 diabetes in children and adolescents: an evolutionary concept analysis. (27 January 2002)
  435. High familial risk and genetic susceptibility in early onset childhood diabetes. (27 January 2002)
  436. Factors influencing remission phase in children with type 1 diabetes mellitus. (27 January 2002)
  437. U.S. Clinical Trial Begins For Diapep277(TM), New Drug Shown To Arrest Progression Of Type 1 Diabetes. (27 January 2002)
  438. ISTA Pharmaceuticals Announces Clinical Trial Results of Vitrase for the Treatment of Diabetic Retinopathy. (27 January 2002)
  439. Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site1. (27 January 2002)
  440. Calcineurin Inhibitor–Free CD28 Blockade-Based Protocol Protects Allogeneic Islets in Nonhuman Primates. (27 January 2002)
  441. Brittle diabetes in the elderly. (27 January 2002)
  442. Impaired intellectual development in children with Type I diabetes: association with HbA1c, age at diagnosis and sex. (20 January 2002)
  443. Clinical Trials Begin for Novel Treatment of Diabetes Mellitus. (20 January 2002)
  444. The Howard Hughes Medical Bulletin from December 2001 includes a report on the institutes efforts related to diabetes. (20 January 2002)
  445. Pregnancy and progression of diabetic nephropathy. (20 January 2002)
  446. Succesful transplantation of human islets in recipients bearing a kidney graft. (20 January 2002)
  447. Increased incidence in post-transplant diabetes mellitus in children: a case-control analysis. (20 January 2002)
  448. Vitamin D and Diabetes. (20 January 2002)
  449. Researchers Find Molecular Link Between Obesity, Diabetes. See also Diabetes: Leptin signal. (20 January 2002)
  450. Effects of Diabetes on Learning in Children concludes that, for most children, type 1 diabetes is not associated with lower academic performance. (13 January 2002)
  451. Islet cell transplantation summarizes islet transplantation today and future developments. (13 January 2002)
  452. JDRF has published a new Research Update. (13 January 2002)
  453. Scientists produce genetically engineered, cloned pigs for xenotransplantation. (13 January 2002)
  454. Amylin Pharmaceuticals Reports Improved Daily Glucose Profiles In Type 1 Diabetes With SYMLIN(TM) Therapy. (13 January 2002)
  455. ISTA Pharmaceuticals Announces Clinical Trial Results of Vitrase For the Treatment of Diabetic Retinopathy. (13 January 2002)
  456. Hepatic Glycogen Metabolism in Type 1 Diabetes After Long-Term Near Normoglycemia. (13 January 2002)
  457. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. (13 January 2002)
  458. "Diabetic Mastopathy," or Sclerosing Lymphocytic Lobulitis, Is Strongly Associated With Type 1 Diabetes. (13 January 2002)
  459. Glucose Metabolism in the First 3 Years after Renal Transplantation in Patients Receiving Tacrolimus versus Cyclosporine-Based Immunosuppression. (13 January 2002)
  460. Eating problems and the observed quality of mother-daughter interactions among girls with type 1 diabetes. (13 January 2002)
  461. Higher urinary IgM excretion in type 2 diabetic nephropathy compared to type 1 diabetic nephropathy. (13 January 2002)
  462. American Diabetes Association And The University Of Florida Announce Plans For $10 Million Statewide Infant Screening Initiative For Type 1 Diabetes. (6 January 2002)
  463. Cerebral Edema in Children with Diabetic Ketoacidosis. (Free registration required) (6 January 2002)
  464. Type 2 Diabetes in Children. (Free registration required) (6 January 2002)
  465. Neurocrine Biosciences and Taisho Pharmaceutical Initiate A Pivotal Phase IIb Clinical Trial for NBI-6024, A Therapeutic Vaccine for the Treatment of Type I Diabetes. (6 January 2002)

[ Current Research News | News from 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]

  Home Return to Top

Last Updated: Thursday January 01, 2015 15:29:00
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.